Pfizer has shifted this fellowship to a forecasted cycle, moving the next anticipated deadline to April 2027. If you plan to apply, note that your program must now include independent research and strong mentorship, whereas clinical training is considered optional. Additionally, a new requirement specifies that no part of your proposed program or budget may benefit Pfizer's business or assets.
Funder: Pfizer Inc.
Due Dates (Anticipated): April 2027 (Full application, projected)
Funding Amounts: Up to $80,000 per one-year fellowship; direct salary and benefits support for one fellow per institution.
Summary: Supports U.S. institutions training gastroenterologists in IBD, with emphasis on diversity, equity, and innovative care and research approaches.
Key Information: Forecasted cycle—dates and details are subject to confirmation.